Biodesix
BDSX
36 hedge funds and large institutions have $5.99M invested in Biodesix in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 19 closing their positions.
16% more call options, than puts
Call options by funds: $163K | Put options by funds: $140K
0.2% less ownership
Funds ownership: 0.67% → 0.47% (-0.2%)
15% less capital invested
Capital invested by funds: $7.06M → $5.99M (-$1.07M)
22% less funds holding
Funds holding: 46 → 36 (-10)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
+$908K |
| 2 |
Renaissance Technologies
New York
|
+$92K |
| 3 |
AF
Allworth Financial
Folsom,
California
|
+$90.8K |
| 4 |
E
Ergoteles
New York
|
+$36.1K |
| 5 |
Morgan Stanley
New York
|
+$29.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$865K |
| 2 |
State Street
Boston,
Massachusetts
|
-$198K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$134K |
| 4 |
Two Sigma Investments
New York
|
-$125K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$123K |
BDSX Hedge Fund Activity: Q2 2022 in Review
36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q2 2022, worth a combined $5.99M — down 15% from $7.06M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of BDSX and 11 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 7 added.
The largest buyer was Birchview Capital, adding an estimated $908K. The largest seller was BlackRock, cutting an estimated $865K.
- 36 institutional investors held Biodesix (BDSX) as of Q2 2022, down from 46 in Q1 2022.
- Funds reported $5.99M of Biodesix stock for Q2 2022, down 15% quarter-over-quarter.
- 11 funds opened new Biodesix positions in Q2 2022 and 19 closed out, a net change of -8 holders.
- The largest Biodesix buyer in Q2 2022 was Birchview Capital, an estimated $908K added.
- The largest Biodesix seller in Q2 2022 was BlackRock, an estimated $865K sold.
Based on aggregated 13F filings for Q2 2022.